Bioheart CEO Mike Tomas Honored for Community and

New Post Public Reply Private Reply Replies (1) Message Board
junewong

Bioheart CEO Mike Tomas Honored for Community and Business Endeavors

Bioheart, Inc. (NASDAQ:BHRT)
Intraday Stock Chart

Today : Monday 25 March 2013

Click Here for more Bioheart, Inc. Charts.

Bioheart, Inc. (OTCQB: BHRT) announced today that Mike Tomas, the Company's President/CEO has received multiple accolades and honors from both national and international assemblages.

This past Saturday Mr. Tomas attended the 12th Annual Torch Awards at Florida International University (FIU). He was bestowed FIU's highest honor; the 2013 Torch Award for lifetime business, community leadership and civic involvement.  https://fiualumni.com/torch2013/

He was also nominated for the 2013 Ernst & Young Entrepreneur of the Year award. The award is considered the world's most prominent business award for entrepreneurs.  http://www.ey.com/US/en/About-us/Entrepreneur...f-The-Year

This June Mr. Tomas will be presented the 2013 Father of the Year award by the American Diabetes Association (ADA). Each year the ADA recognizes men from the U.S.A. for the outstanding strength, commitment and love they exhibit as fathers.  http://main.diabetes.org/site/PageServer?page...=MikeTomas

"I am sincerely honored to be recognized by these exceptional organizations. I endeavor to make a positive difference in the lives of others and to push forward on opportunities," said Mr. Tomas.

In the past year, Mike Tomas was inducted into the Miami Dade College Hall of Fame and welcomed into the World Assembly and Council (WACE) Hall of Fame.

Dr. William P. Murphy Jr., Chairman of the Board commented, "Bioheart is fortunate to have someone of Mike's caliber leading our company. His business acumen has been proven time and again throughout his career. He has led his many business ventures to success and I feel confident that Bioheart will be no exception."

About Bioheart, Inc.

Bioheart is committed to maintaining its leading position within the cardiovascular sector of the cell technology industry delivering cell therapies and biologics that help address congestive heart failure, lower limb ischemia, chronic heart ischemia, acute myocardial infarctions and other issues. Bioheart's goals are to cause damaged tissue to be regenerated, when possible, and to improve a patient's quality of life and reduce health care costs and hospitalizations.

Specific to biotechnology, Bioheart is focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage and peripheral vascular disease. Its leading product, MyoCell, is a clinical muscle-derived cell therapy designed to populate regions of scar tissue within a patient's heart with new living cells for the purpose of improving cardiac function in chronic heart failure patients. For more information on Bioheart, visit  www.bioheartinc.com , or visit us on Facebook: Bioheart and Twitter  @BioheartInc .

About Mike Tomas 

Mike Tomas was appointed as Bioheart's President, CEO and a Director on June 19, 2010. For the past 11 years, he has served as President of The ASTRI Group, an early stage private equity investment company in Florida with an investment in Bioheart. In 2003, he joined Bioheart's Board of Directors as the independent representative of The ASTRI Group. Prior to this, Tomas held ascending executive positions including Chief Marketing Officer at Avantel, a $1 billion dollar joint venture with MCI. He currently sits on the boards of Perimeter Internetworking, Avisena and Total Home Health. He is also the current chairman of the Global Entrepreneurship Center at Florida International University and a founding coach/mentor at the University of Miami's Launch Pad at the Toppel Center. Mike holds a Masters of Business Administration from the University of Miami, a Bachelor degree from Florida International University and an Associate degree from Miami Dade College.

Forward-Looking Statements: Except for historical matters contained herein, statements made in this press release are forward-looking statements. Without limiting the generality of the foregoing, words such as "may," "will," "to," "plan," "expect," "believe," "anticipate," "intend," "could," "would," "estimate," or "continue" or the negative other variations thereof or comparable terminology are intended to identify forward-looking statements.

Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Also, forward-looking statements represent our management's beliefs and assumptions only as of the date hereof. Except as required by law, we assume no obligation to update these forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

The Company is subject to the risks and uncertainties described in its filings with the Securities and Exchange Commission, including the section entitled "Risk Factors" in its Annual Report on Form 10-K for the year ended December 31, 2011, and its Quarterly Report on Form 10-Q for the quarter ended September 30, 2012.

Bioheart, Inc.

13794 NW 4th Street

Suite 212

Sunrise, FL 33325

Telephone 954-835-1500

Email:  rmadaris@bioheartinc.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cooper's Heat Pump Campaign Fuels Denver's Community

Updated Category News Views 124

How Heat Pumps Meet Philanthropy in Denver Alright, let me lay it out for you—a story as much about ingenuity as generosity. Cooper Heating & Cooling, donning their ‘Cooper Green Team’ capes, just wrapped up one heck of a community-driven campaign. They dropped a cool $5,000 into the coffers of We Don't Waste, a Denver nonprofit focused on food recovery. This...

Continue Reading
Ares Management Faces Fintech with $691B Assets

Updated Category News Views 170

Anticipation Builds: Ares Awaits TD Cowen Spotlight Ah, Ares Management, the Wall Street heavyweight clocking a colossal $691 billion in assets. Now, they’re angling to dish out some strategic insights. With the TD Cowen 2026 Financials & Fintech Conference set to roll on November 18, what’s better than watching these investment titans take the stage with their CFO...

Continue Reading
Surgery Partners and ADT Sales Under Legal Scrutiny

Updated Category News Views 6

Shareholder Scrutiny on Mergers It's no secret that corporate mergers often kick up a fuss, but when insiders get a juicy payday while regular shareholders play catch-up, folks raise eyebrows. Halper Sadeh LLC, that gutsy law firm, isn't shy about going after possible dirty deals, and they've got their eyes on a few names related to potential securities law violations and...

Continue Reading
BD Sets Stage for Investor Day in December 2026

Updated Category News Views 61

BD's Investor Day: A Peek into the Future Say what you will about investor meets, but BD (Becton, Dickinson and Company) throwing its shindig on December 10, 2026, could be a highlight on the calendar if you're eyeing the medical technology sector. Scheduled in New York, this event is gearing up to be a canvas for BD's higher-ups to sketch out their roadmap. If you’re...

Continue Reading
Gulliver Prep's New STEAM Complex to Transform Miami

Updated Category News Views 0

Gulliver Prep Leads the Charge in Education Innovation Gulliver Preparatory School just dropped a bombshell in Miami—almost literally, with their shovels hitting the dirt for a new 95,000-square-foot STEAM complex. It's not some lip-service to educational buzzwords either. This project's part of 'The Next 100: The Centennial Campaign for Gulliver,' a mega drive to...

Continue Reading
IASO Bio's In Vivo CAR-T: A Game Changer for Oncology?

Updated Category News Views 52

You ever feel like you're watching history happen right in front of you? That's the vibe with IASO Bio's latest move in the realm of oncology. This outfit just scored a major victory, getting China's NMPA and the U.S. FDA to greenlight their IASO208, a CD20-targeting in vivo CAR-T therapy. It's not every day you see a company land dual regulatory nods like...

Continue Reading
Real Estate Decisions in Hospitality: Buy or Lease?

Updated Category News Views 0

Venturing into Hospitality Real Estate If you're in the hospitality game, the question of whether to buy or to lease your property can loom like a shadow or shine like an opportunity. The latest episode of the Owner's Edge Podcast by Bielat Santore & Company dives into this headfirst, armed with over 45 years of brokering experience in hospitality transactions. They don't...

Continue Reading
O-I Glass Faces Class Action: What Investors Must Know

Updated Category News Views 35

The Unsettling News for O-I Glass Investors Let me dive right into this mess about O-I Glass, Inc. (NYSE:OI). If you're tangled up in their stock, you probably felt that 15.01% nosedive in your portfolio recently. That's no minor blip. On July 28, 2026, as stocks were virtually put through the shredder, O-I Glass announced they had to cut down their financial guidance for...

Continue Reading
Gilat's Revenue Dip Spurs Legal Scrutiny for Investors

Updated Category News Views 51

Gilat Satellite's Surprise Revenue Shortfall If anybody thought the satellite business was all about science fiction-esque technology, here's a reality check: when earnings don't meet expectations, shareholders get jittery. This seems to be exactly what's happening with Gilat Satellite Networks Ltd. (NASDAQ: GILT). After twice reaffirming their fiscal 2026 revenue...

Continue Reading
Insulin Delivery Devices: A Billion-Dollar Surge

Updated Category News Views 20

When's the last time you saw a medical device market promising a $10 billion leap in under five years? Yeah, the insulin delivery devices market's got that kind of upside, projected to skyrocket from $16.92 billion in 2026 to a whopping $26.37 billion by 2031. That's a 9.3% annual growth rate. The numbers and the stakes are both staggering. Regional and Segment Leaders...

Continue Reading

Top 5 Most Recently Viewed Articles

Joint SEC and CFTC Initiative Aims to Revolutionize Crypto Regulation

Updated Category News Views 178

SEC and CFTC Collaboration to Enhance Crypto Regulations The Securities and Exchange Commission and the Commodity Futures Trading Commission have recently announced a collaborative initiative aimed at simplifying the trading process of cryptocurrency assets. This collaboration indicates a forward-thinking approach to regulation in the rapidly evolving digital asset space....

Continue Reading
New Leadership Transition at Century Lithium Corp.

Updated Category News Views 124

Century Lithium Announces CFO Transition Century Lithium Corp. has made an important announcement regarding a shift in its executive leadership. Mr. Braam Jonker will soon step down from his role as Chief Financial Officer effective September 30, allowing him to pursue different ventures. To fill this crucial position, Matthew Tompkins, who has been with the company as...

Continue Reading
Earlyworks Co., Ltd. Shows Strong Financial Growth in 2024

Updated Category News Views 183

Earlyworks Co., Ltd. Reports Financial Performance TOKYO, March 3, 2025 -- Earlyworks Co., Ltd. (NASDAQ: ELWS), a leading provider of blockchain technology solutions, has announced its financial results for the first six months ended October 31, 2024. The company has demonstrated a substantial increase in revenue and a notable reduction in losses compared to the previous...

Continue Reading
Parsons Corporation Expands Portfolio with CTI Acquisition

Updated Category News Views 172

Parsons Corporation Acquires Chesapeake Technologies International Parsons Corporation has made a significant move by acquiring Chesapeake Technologies International, Corp (CTI), a strategic framework to bolster its defense and intelligence services. This acquisition marks a pivotal event in the growth trajectory of Parsons, as it positions the company to expand its...

Continue Reading
Elon Musk's Praise for Larry Ellison Sparks Fascination

Updated Category News Views 147

Elon Musk's Admiration for Larry Ellison Elon Musk recently expressed admiration for Oracle’s Chief Technology Officer Larry Ellison following the resurfacing of an old video. This moment has captured the interest of many tech enthusiasts and fans alike. Highlights from the Resurfaced Video The video in question features Ellison at Oracle Open World 2018, where he...

Continue Reading